Showing results (361-370 of 386) with videos related to

Sort By:
Pageof 39
International Journal of Cancer|October 24, 2018
Combined genetic and epigenetic alterations of the TERT promoter affect clinical and biological behavior of bladder cancerRicardo Leão, Donghyun Lee, Arnaldo Figueiredo, et al.
European Urology Oncology|September 25, 2025
Prognostic Significance of the Cytoplasmic Expression of UDP-glucuronosyltransferase 2B17 in Localized Prostate Cancer: Insights from the Canadian Prostate Cancer Biomarker Network and PROCURE Multi-institutional CohortsAshwini Uchil, Louis Lacombe, Hélène Hovington, et al.
The Lancet. Oncology|May 15, 2023
Radical cystectomy versus trimodality therapy for muscle-invasive bladder cancer: a multi-institutional propensity score matched and weighted analysisAlexandre R Zlotta, Leslie K Ballas, Andrzej Niemierko, et al.
Prostate Cancer and Prostatic Diseases|December 14, 2018
Validation of the Decipher Test for predicting adverse pathology in candidates for prostate cancer active surveillanceHyung L Kim, Ping Li, Huei-Chung Huang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2017
Neoadjuvant Enzalutamide Prior to ProstatectomyBruce Montgomery, Maria S Tretiakova, Anthony M Joshua, et al.
Urologic Oncology|January 10, 2017
Quality indicators in the management of bladder cancer: A modified Delphi studySatya R Khare, Armen Aprikian, Peter Black, et al.
European Urology|October 8, 2025
Development and International Evaluation of an Artificial Intelligence-based Model (PROGRxN-BCa) Using the World Health Organization 2004/2022 Grading System to Predict Progression Risk and Improve Substratification for Non-muscle-invasive Bladder CancerJethro C C Kwong, Zizo Al-Daqqaq, Yashan Chelliahpillai, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|May 25, 2016
Enumerating pelvic recurrence following radical cystectomy for bladder cancer: A Canadian multi-institutional studyLibni J Eapen, Edward Jones, Wassim Kassouf, et al.
The Oncologist|February 23, 2024
Extended Safety and Tolerability of Darolutamide for Nonmetastatic Castration-Resistant Prostate Cancer and Adverse Event Time Course in ARAMISNeal D Shore, Christian Gratzke, Susan Feyerabend, et al.
BJU International|February 7, 2023
Prognostic impact of variant histologies in urothelial bladder cancer treated with radical cystectomyFrancesco Claps, Maaike W van de Kamp, Roman Mayr, et al.
Pageof 39